Engineering Biomimetic Biosensor Using Dual‐Targeting Multivalent Aptamer Regulated 3D DNA Walker Enables High‐Performance Detection of Heterogeneous Circulating Tumor Cells
Small · 2023
DOI: 10.1002/smll.202302542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Lanlan Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, P. R. China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Aptamers, Nucleotide, Biosensing Techniques. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The phenotypic heterogeneity of circulating tumor cells (CTCs) and the nonspecific adsorption of background cells impede the effective and sensitive detection of rare CTCs. Although leukocyte membrane coating approach has a good antileukocyte adhesion ability and holds great promise for addressing the challenge of capture purity, its limited specificity and sensitivity prevent its use in the detection of heterogeneous CTCs. To overcome these obstacles, a biomimetic biosensor that integrated dual‐targeting multivalent aptamer/walker duplex functionalized biomimetic magnetic beads and an enzyme‐powered DNA walker signal amplification strategy is designed. As compared to conventional leukocyte membrane coating, the biomimetic biosensor achieves efficient and high purity enrichment of heterogeneous CTCs with different epithelial cell adhesion molecule (EpCAM) expression while minimizing the interference of leukocytes. Meanwhile, the capture of target cells can trigger the release of walker strands to activate an enzyme‐powered DNA walker, resulting in cascade signal amplification and the ultrasensitive and accurate detection of rare heterogeneous CTCs. Importantly, the captured CTCs remained viable and can be recultured in vitro with success. Overall, this work provides a new perspective for the efficient detection of heterogeneous CTCs by biomimetic membrane coating and paves the way for early cancer diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, P. R. China.
- Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis, Xi'an, 710061, P. R. China.
- School of Medicine, Tibet University, Lhasa, 850000, P. R. China.
ORCID-Profile: Xiaoyu Xie
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jia, L., Hu, Q., Zhang, T., Wang, Z., Wu, D., Xie, X., & Wang, S. (2023). Engineering Biomimetic Biosensor Using Dual‐Targeting Multivalent Aptamer Regulated 3D DNA Walker Enables High‐Performance Detection of Heterogeneous Circulating Tumor Cells. Small. https://doi.org/10.1002/smll.202302542
Vancouver
Jia L, Hu Q, Zhang T, Wang Z, Wu D, Xie X, et al. Engineering Biomimetic Biosensor Using Dual‐Targeting Multivalent Aptamer Regulated 3D DNA Walker Enables High‐Performance Detection of Heterogeneous Circulating Tumor Cells. Small. 2023. doi:10.1002/smll.202302542
BibTeX
@article{Jia2023,
author = {Jia, Lanlan and Hu, Qi and Zhang, Tingting and Wang, Zhaojia and Wu, Dan and Xie, Xiaoyu and Wang, Sicen},
title = {Engineering Biomimetic Biosensor Using Dual‐Targeting Multivalent Aptamer Regulated 3D DNA Walker Enables High‐Performance Detection of Heterogeneous Circulating Tumor Cells},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202302542}
}
EUVIMED